What are users saying in their Sciatilief review about pain relief?
admin Sciatilief review about pain relief Nerve pain can be a deeply frustrating and debilitating condition, affecting everything from…
Medicine
Are there discounts or promotions when I Buy VELO Online Philippines?
Buy VELO Online Philippines If you are looking to Buy VELO Online Philippines, you might be wondering whether…
服用 Saxenda 期間應避免什麼？
期間應避免什麼 Saxenda 是我們香港醫療中心最受歡迎的減肥藥物之一，許多患者透過它來幫助控制體重並改善健康。然而，在服用 Saxenda 期間，為了確保藥效最佳並減少副作用，有一些事項需要特別注意並加以避免。 首先，患者在使用 Saxenda 時應避免高熱量、高糖分和高脂肪的飲食。雖然 Saxenda 能夠幫助抑制食慾，但如果仍然攝取大量高熱量食物，可能會降低減重效果，甚至導致體重無法下降。因此，在服用 Saxenda 的同時，應該搭配健康均衡的飲食，如多攝取蔬菜、瘦肉、全穀類和健康脂肪，避免含糖飲料、加工食品和油炸食物，以確保體重管理的效果更加顯著。 其次，服用 Saxenda 期間應避免大量飲酒。酒精不僅含有大量熱量，還可能影響血糖控制，導致血糖波動，特別是對於有糖尿病或血糖不穩定的患者而言，酒精的影響可能更為明顯。此外，酒精還可能加重 Saxenda 的某些副作用，例如噁心、胃部不適或頭暈，因此建議患者減少或避免飲酒，以降低不適感並確保治療的順利進行。 服用…
Lantheus acquires radiopharma CDMO Evergreen
The US radiopharmaceuticals giant Lantheus is snapping up the Contract Development and Manufacturing (CDMO) Evergreen Theragnostics as it…
Ethris reports positive phase 1 results for ETH47 mRNA asthma treatment
Munich-based biotechnology company Ethris has announced encouraging topline data from a phase 1 clinical trial evaluating its lead…
Novo Nordisk reports 22% weight loss with amycretin
Novo Nordisk has reported weight loss effects of up to 22% in patients who received a weekly subcutaneous…
Manas AI launches with $24.6 million seed round
The round was led by the US venture capital (VC) firm General Catalyst Partners with participation from compatriot…
Applying data to real-world challenges
Head of solution value at One2Treat, Émilie Barré shares her journey to date with Outsourcing-Pharma. Could you give…
The largest pharma acquisitions of 2024
Compared to the previous years, 2024 has been a relatively slow year for mergers and acquisitions in the…
Arctic therapeutics secures funding for groundbreaking dementia and acne treatments
Arctic Therapeutics announced this week that it has raised €26.5 million, a sum bankrolled by investors including the…
Trial shows high-dose Wegovy can increase weight loss effects
Results from the STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight…
BioCina and NovaCina join forces in merger
Australian contract development and manufacturing organizations (CDMOs), BioCina and NovaCina, have merged in a move to pool their…
AI proving critical in clinical trial design
We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the…
Spotlight on patient centricity in clinical trials
We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape…
Medable Showcases AI-Powered Innovations at SCOPE 2025
Stakeholders across the clinical trials and digital health industry will be gathering next month in Orlando at the…
Tech key to accelerating clinical trial outcomes
Ashley Davidson, vice president of sponsor and tech strategy at Advarra, discusses her outlook for this year’s edition…
WCG’s outlook for SCOPE 2025
As pharmaceutical pipelines and R&D investments expand worldwide, the global market for clinical trials is projected to grow…
Patient Perspectives and Multidimensional Assessments
The evolution of clinical trials is being driven by an increased focus on patient perspectives and innovative statistical…
Johnson & Johnson acquires Intra-Cellular Therapies in $14.6bn deal
Johnson & Johnson has entered an acquisition agreement with drug developer Intra-Cellular Therapies priced at $14.6bn, positioning the…
Scope Summit 2025 award finalists announced
As the Cambridge Healthtech Institute (CHI) celebrates its 16th annual Clinical Ops Executives (SCOPE) Summit in Orlando, Florida,…
Anthem Biosciences plans IPO worth $397m
As India’s contract manufacturing and development organization (CDMO) is set to double in the next decade, Anthem Biosciences…
Verdiva Bio’s launch is backed by financing of over $410m
The company’s launch is backed by an oversubscribed Series A round of $411m co-led by Forbion and General…
Denali’s ALS Drug DNL343 Misses Key Trial Endpoint
Denali Therapeutics has announced topline results from the phase 2/3 Healey ALS Platform Trial, which evaluated the effects…
Orbis Medicines bags €90 million Series A
Orbis was founded in 2021 by the Seeds Investment team of Novo Holdings, the assets and wealth manager…
Bremelanotide: Promising Diabetic Nephropathy Treatment
Palatin Technologies has announced topline results for the phase 2b Breakout study, which evaluated the effects of bremelanotide…
Gilead taps into Terray’s AI-based drug discovery
According to the terms of the deal, Gilead will select a set of drug targets and Terray will…
Brazil’s Nintx bags $10m for plant-based drugs
Founded by a team of scientists and healthcare specialists in 2021, Nintx harnesses compounds from Brazil’s world-famous plant…
AbbVie acquires Nimble for oral peptides
AbbVie and Nimble Therapeutics have announced an acquisition deal in which AbbVie will gain ownership of the company’s…
Noema Pharma Secures $147M to Advance CNS Disorder Treatments
Noema Pharma has announced an extension of its series B financing round, bringing the total raised up to…
General Inception acquires Enable Medicine
The company creator General Inception (GI) has acquired Enable Medicine to pool its know-how regarding drug development and…
Eli Lilly expansion set to add 750 skilled jobs to Wisconsin site
Shortly after acquiring a manufacturing site in Wisconsin, Eli Lilly intends to expand it to boost its production…
AbbVie set to file for FDA approval on tavapadon
Pharma company, AbbVie, reports that its D1/D5 partial agonist, tavapadon, has met the primary and secondary endpoints in…
PTC Therapeutics boosted by Novartis rights deal for Huntington’s program
PTC Therapeutics announced this week that it has made a deal with Novartis for global rights to its…
Mitsubishi and Dewpoint team up to tackle ALS
The pharma arm of Mitsubishi Chemical Group has launched a collaboration with US-based Dewpoint Therapeutics to co-develop a…
Investment in radiopharmaceuticals is ramping up
Investment in radiopharmaceuticals is ramping up as big pharma shows a growing appetite for this promising drug modality.…
Körber absorbs Bähren to expand pharma packaging
The pharmaceutical business unit of the German giant Körber has snapped up the compatriot label and leaflet supplier…
Novocure’s TTFields therapy boosts survival in pancreatic cancer
Swiss oncology specialist Novocure has announced positive topline results from the PANOVA-3 phase 3 clinical trial, which evaluated…
Tech-driven solutions for patient access
While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to…
Overcoming nonspecific binding challenges in PK assays
However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and…
Diabetes prevention – Eli Lilly’s Tirzepatide shows 23% weight loss
Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight…
AstraZeneca invests $3.5BN to boost US manufacturing power
With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is…
Phase 3 success for AstraZeneca prostate drug
AstraZeneca has reported positive results from the CAPItello-281 phase 3 trial, which evaluated Truqap (capivasertib) in combination with…
FDA grants orphan drug designation to CervoMed’s dementia drug
The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational…
Portugal’s Hovione builds spray drying capacity in US and Ireland
Spray drying involves converting pharmaceutical liquid solutions into tiny droplets that are rapidly dried with hot gases such…
Adragos Pharma snaps up Baccinex to expand CDMO network
Founded in Munich in 2020, Adragos’ global manufacturing sites were acquired from other players including Haupt Pharma Livron,…
We’ve upgraded Outsourcing Pharma to give you more of what you love
What’s new at leading trade publication Outsourcing Pharma
Decentralized clinical trials market expected to grow to $25BN
According to a recent report by Business Research Insights, the total size of the global decentralized clinical trials…
Equity boost and partnership aim to accelerate GEMS platform’s efficiency
NVentures also participated in the company’s $200 million Series B last August. This strengthened collaboration is aimed at…
How eCOA/ePRO is transforming clinical trials
eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and…
C Ray Therapeutics $100M to improve RDC technology platform
C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100…
Promising phase 2 results for Eli Lilly’s Muvalaplin
Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against…
Chemistry passion to industry leadership
Now the Global market development manager at Phenomenex, she thrives on connecting insights with solutions, all while channeling…
From lab to leading biopharma innovation
Now leading the Biopharma product management team at Phenomenex, she brings a problem-solving mindset honed by a love…
Samsung Biologics and European pharma company enter major manufacturing deal
The global contract development and manufacturing organization (CDMO), Samsung Biologics, announced this week that it has entered into…
Pfizer’s HYMPAVZI wins EU approval for hemophilia A and B care
The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment,…
Drug-free pain relief for knee osteoarthritis
Sameer Sabir, CEO and Co-Founder of Brixton Biosciences (Brixton Biosciences) Sameer Sabir, CEO and co-founder of Brixton Biosciences,…
Icotrokinra ‘best in class oral therapeutic for plaque psoriasis’
The phase 3 ICONIC-LEAD study showed that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was…
Icotrokinra ‘best in class oral therapeutic for plaque psoriasis’
The phase 3 ICONIC-LEAD study showed that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was…
Pfizer’s HYMPAVZI wins EU approval for hemophilia A and B care
The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment,…
C Ray Therapeutics $100M to improve RDC technology platform
C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100…
Promising phase 2 results for Eli Lilly’s Muvalaplin
Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against…
Coronado’s CSO champions data-driven innovation in clinical trials
At the helm of Coronado’s scientific strategy, Professor Visser-Rogers envisions a data-driven future powered by innovative methodologies and…
Gifthealth partners with United Digestive
Gifthealth has announced a strategic partnership with United Digestive, a leading practice management organization for gastroenterology. This is…
Patients prefer telehealth for clinical trials, survey shows
Conducted with 136 US-based participants across multiple health conditions, the survey found that 63% said they would be…
AI-driven Medable Studio speeds digital trial startups
Medable, a provider of clinical development technology, has announced a collaboration with Google Cloud to bring its decentralized…
Overcoming nonspecific binding challenges in PK assays
However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and…
Diabetes prevention – Eli Lilly’s Tirzepatide shows 23% weight loss
Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight…
Equity boost and partnership aim to accelerate GEMS platform’s efficiency
This forms part of an expanded partnership to enhance Genesis’ AI-powered drug discovery platform, GEMS (Genesis Exploration of…
AstraZeneca invests $3.5BN to boost US manufacturing power
With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is…
Decentralized clinical trials market expected to grow to $25BN
According to a recent report by Business Research Insights, the total size of the global decentralized clinical trials…
Tech-driven solutions for patient access
While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to…
GHO and Ampersand acquire CDMO Avid Bioservices for $1.1 billion
Under the terms of the merger agreement, Avid Bioservices will be acquired by funds managed by GHO and…
Merck, Abbisko’s oral drug aces phase 3 for rare tumors
According to the topline results, a total of 54% of patients given the treatment saw their tumors shrink…
Dexter Tjoa on Tjoapack’s journey and future in packaging
CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced technologies for…
Axonis raises $115 million to treat epilepsy
Epilepsy is one of the most common neurological conditions in the world, with around 50 million people with…
Abzena unveils cell Line and ADC innovations at CPHI 2024
By offering comprehensive, integrated solutions, Abzena aims to streamline drug development processes and minimize risks for customers, helping…
Czy vape peny są bezpieczniejsze niż tradycyjne papierosy?
Czy vape peny są bezpieczniejsze niż tradycyjne Vape pen to przenośne urządzenie, które podgrzewa aromatyzowany płyn, aby wytworzyć…
Middle School MD fosters youth interest in medical careers
The Palomar Health Foundation recently completed its third annual Middle School Medical Discoveries (Middle School MD) program, engaging…
Novo Nordisk signs $285 million deal for a once-monthly Wegovy
Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license to its TransCon technology platform for the development,…
Senhwa Biosciences starts trial of drug for rare cancers in children
Silmitasertib, also known as CX-4945, was originally developed by Cylene Pharmaceuticals, a San Diego-based biotech that ceased operations…
Veeva’s Tim Davis on overcoming eCOA deployment challenges
Tim Davis, vice president of strategy at Veeva eCOA, had a conversation with Outsourcing Pharma’s senior editor, Liza…
MD Anderson investment supports groundbreaking cancer therapies
Starget Pharma, an Israeli startup developing AI-powered precision therapies for difficult-to-treat cancers, has secured a $5.1 million investment…
Novo Nordisk study – semaglutide reduces hospital admissions
Novo Nordisk has released data from the SELECT phase 3 trial showing that a 2.4 mg dose of…
First-line leukemia therapy granted accelerated approval by FDA
Novartis’ Scemblix (asciminib) has received accelerated approval by the US FDA as a treatment for adult patients with…
AI-driven outreach boosts therapy start, adherence rates
A new case study from AllazoHealth demonstrates that a top 10 rare disease pharmaceutical company experienced a 10.4%…
Labguru ELN integration enhances Thermo Fisher LIMS capabilities
This integration aims to create a unified lab management experience, offering scientists enhanced data traceability, security, and streamlined…
Vicky Marriott on leading with empathy in science and statistics
In an exclusive interview, Vicky shares insights on her career, the challenges she faced, and her passion for…
Enhancing pharma manufacturing with digital twin technology
From reducing operational costs to enhancing patient outcomes, Stevanato Group is at the forefront of digital transformation in…
GLP-1 market heats up as companies vie for next-gen obesity drugs
Since the FDA approval of Novo Nordisk’s Wegovy as a treatment for chronic weight management in 2021, followed…
Axonis raises $115 million to treat epilepsy
Epilepsy is one of the most common neurological conditions in the world, with around 50 million people with…
Anu Codaty’s path to biotech leadership
With a background spanning biotech and executive roles at Medtronic, Anu brings a unique blend of resilience, collaboration,…
NovAliX and Bruker forge alliance to boost drug discovery
This alliance marks a shift in biopharma R&D, with the launch of the Biophysics Institute for Biomedical Research…
Rentschler Biopharma to boost production with new buffer media station
Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) will be increasing its production at its headquarters…
GSK beefs up US manufacturing with $800 million
GSK is one of the world’s biggest pharmaceutical companies with products ranging from the shingles vaccine Shingrix and…
Merck acquires Modifi Biosciences in $1.3B cancer drug deal
Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for…
NorthStar launches radiopharmaceutical CDMO
Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as…
Merck acquires Modifi Biosciences in $1.3B cancer drug deal
Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for…
NorthStar launches radiopharmaceutical CDMO
Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as…
PTC Therapeutics DMD drug misses regulatory hurdle
The EU first gave Translarna a conditional marketing authorization in 2014 for the treatment of DMD, a progressive…
Donanemab Alzheimer’s drug approved by MHRA, rejected by NICE
A new Alzheimer’s treatment, donanemab, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), but…
Boston biotech secures funds to advance depression, anxiety drug
Seaport has developed a platform called Glyph designed to enhance efficacy and reduce the side effects of potential…
PTC Therapeutics DMD drug misses regulatory hurdle
The EU first gave Translarna a conditional marketing authorization in 2014 for the treatment of DMD, a progressive…
Acquisition adds late-stage drug candidate with blockbuster potential
Lundbeck and Longboard Pharmaceuticals have announced an agreement for the Danish pharmaceutical company to acquire all outstanding shares…
The industry is opening up to techbio – panel highlights
Techbio is a field where the computational expertise of the tech sector and the biological know-how of the…
Women in Science – SCIEX Rebekah Sayers
Find out all about her intriguing journey to where she is now in her role as marketing manager…
Jane Koo’s role in advancing cancer therapies at CTMC
With a career spanning monoclonal antibodies and now cell therapies, she expertly navigates complex regulatory landscapes to bring…
Corden Phama – staying on top of manufacturing trends
Outsourcing Pharma caught up with experts from the global CDMO, CordenPharma, to learn how they maintain their competitive…
Sanofi halts Denali’s MS drug trial after phase 2 failure
The K2 trial tested oditrasertib’s safety and ability to reduce the blood levels of neurofilament light chain, a…
Precision dosing expert Sharmeen Roy
With a background in pharmacy and specialized pediatric care, she now bridges bioinformatics with practical, user-friendly tools, empowering…
From researcher to market leader at SCIEX
Now a global market development manager, she plays a pivotal role in shaping solutions for food safety and…
Enzene targets cost savings and efficiency
The significant advantages it offers include: Large reduction in COGS: By 2025, EnzeneX 2.0 expects to produce 40…
SGD Pharma to showcase new glass packaging solutions at CPHI 2024
These siliconized vials are designed to protect sensitive, aggressive, and viscous drug products by reducing interactions with the…
Third-generation lung cancer therapy commercialized
Innovent Biologics and Jiangsu Aosaikang Pharmaceutical (Ask Pharm) have announced a strategic collaboration regarding limertinib, a third-generation epidermal…
Evaxion AI platform identifies cancer vaccine targets in trials
Danish techbio company Evaxion Biotech has published results showing the outcome of three clinical trials comparing the prediction…
AstraZeneca strikes $2 billion deal with CSPC
Dyslipidemia, a condition involving unhealthy levels of cholesterols and other fats in the blood, is a major risk…
FDA clearance to start clinical trials with new obesity drug
Antag Therapeutics has announced that the FDA has accepted the investigational new drug (IND) application for its lead…
Will AI live up to its promise and how will it impact global health?
One area it is thriving is pharmaceuticals as it is being used to bring drugs to market faster…
How will the Biosecure Act impact the pharma industry?
But what does the Act mean for the biotech and pharma industry and how can companies best prepare…
Will the Biosecure Act impact the pharma industry?
But what does the Act mean for the biotech and pharma industry and how can companies best prepare…
Recipharm bolsters global production facilities
One of Recipharm’s main aims is the expansion of its oral solid dosage and sterile fill & finish…
Big reveals for dsm-firmenich at CPHI 2024
Located at booth 3B25 (API Hall 3), the company says it will demonstrate its ongoing commitment to advancing…
Adragos Pharma and the evolving world of outsourcing
We also delve into the latest trends, the rise of AI and the increasing focus on sustainability. How…
Big reveals for dsm-firmenich at CPHI 2024
Located at booth 3B25 (API Hall 3), the company says it will demonstrate its ongoing commitment to advancing…
FDA compliance and AI drive growth for Quotient
He will also be explaining how the company is expanding its Translational Pharmaceutics platform into new therapeutic areas…
Optimizing patient recruitment for faster clinical trials
The success of these trials hinges on finding and enrolling the right patients in a timely manner. Eben…
Symbiosis unveils expanded facility at CPHI Milan 2024
The event provides a great platform for the company to present its newest addition—a 20,000 sq ft facility…
Ardena expands bioanalytical and GMP services
The company explains attendees will gain insight into how Ardena’s innovations can streamline drug development for advanced therapies,…
Women in Science – SCIEX Rebekah Sayers
Find out all about her intriguing journey to where she is now in her role as marketing manager…
SK pharmteco invests $260M in small molecules
The expansion involves setting up a new facility, which is planned to begin operations in late 2026. The…
LoQus23 raises £35M to advance Huntington’s disease therapy
UK-based company LoQus23 Therapeutics has announced the closing of a £35 million series A round to advance its…
Stevanato to launch Vertiva 10mL on-body system at CPHI 2024
The company says this new platform is specifically designed to administer large-volume injectable therapies, including highly viscous biological…
Sequentia Biotech bags €10m for omics products
Sequentia will use the round winnings to speed up the market introduction of its cloud-based and microbiome-focused healthcare…
The impact of AI technology in pharmacovigilance
Eric Prugh is the chief product officer at Authenticx, a US-based company that recently launched an AI solution…
From philosophy to biochemistry – Women in Science
With a passion for problem-solving and sustainability, her journey into science began with a fascination for philosophy and…
Pfizer withdraws sickle cell drug over safety
The withdrawal decision was prompted by clinical data indicating that the overall benefit of Oxbryta “no longer outweighs…
AbbVie reports positive phase 3 results for Parkinson’s drug
The oral, specific dopamine agonist met its primary endpoint in the trial, which is the second of three…
Biohaven’s troriluzole shows promise in spinocerebellar ataxia
Biohaven, which spun out of Biohaven Pharmaceuticals in 2022 when its parent company was acquired by Pfizer, has…
Miplyffa bags FDA approval for ultra-rare disease
NPC is a progressive disease where the patient has a mutation in NPC1 or NPC2 – genes that…
YPrime COO Alison O’Neill -‘pursue what you enjoy and be flexible’
She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In…
Nura Bio secures $140M to advance lead drug to next trials
Nura Bio has announced the addition of $68 million to its series A financing, closing the round with…
Insilico’s lead drug meets safety and efficacy goals in IPF trial
Insilico Medicine, a biotech company with offices in both China and the US, announced this week that its…
uMotif acquires ClinOne, integrates eConsent for clinical trials
Announced on September 4, 2024, this acquisition positions uMotif to enhance its existing capabilities by integrating ClinOne’s enterprise…
F2G raises $100M to advance olorofim after FDA rejection
Infections caused by Aspergillus species of mold are transmitted through inhalation and can lead to symptoms including hypersensitivity…
German pharma to submit FDA application after nerandomilast success
Boehringer Ingelheim reported this week that its phase 3 Fibroneer-IPF trial had met its primary endpoint of an…
CluePoints unveils expert speaker line-up for RBQMLive 2024
As the premier sponsor, CluePoints is helping to elevate RBQMLive as the industry’s leading event focused on the…
Women in Science – Vaxess CEO on owning your seat at the table
She is CEO of Vaxess and wants to be able to deliver therapeutics in the most patient-friendly and…
EORTC extends Medidata partnership to advance data-driven cancer research
The four-year extension focuses heavily on enhancing data management in oncology research, allowing EORTC to streamline patient access…
Slope unveils tech-enabled solutions to optimize clinical trial data
The company’s latest offering empowers clinical trial sponsors to harness the full potential of their biospecimen data, transforming…
Envision Pharma Group unveils new data management platform
The company says this new data and analytics management solution marks a significant shift in how medical affairs…
Optimize clinical trials with Phastar’s RBQM app & analytics
The tool supports critical RBQM processes like risk assessment, central monitoring, issue management, risk reassessment, targeted site monitoring,…
ethics and AI in healthcare marketing
Leslie Pascaud, chief marketing officer at ObvioHealth, believes the key to effective marketing remains grounded in three fundamentals:…
AI and a growing confidence in transforming drug development
In this Q&A, Dr Fabrice Chartier (FC), CEO of Simbec-Orion and Joern Klinger (JK), CEO of biotx.ai explore…
Remote dosing and culturally informed OUD solutions
The report, called ‘The strategic allocation of opioid settlement funds – an evidence-based approach to preventing deaths from…
The need for new clinical trial designs in cancer
Ravi Karra, VP of Oncology at the service provider Advanced Clinical, explains how advanced imaging techniques and trial…
Women in Science – Cytiva’s Emannuelle Cameau
Read our interview to discover how losing her beloved horse ended her desire to be a vet to…
AI-enabled platform by Creyon Bio receives second US Patent
This patent protects the company’s proprietary Creyon platform, which rapidly engineers and optimizes OBMs, marking a significant advancement…
New report investigates pharma’s global reach and impact
A new report from the Access to Medicine Foundation takes a groundbreaking look at how some of the…
Women in Science – Cytiva’s Beate Mueller
With a passion for science and an ‘eternal technology optimist’, she says playing a role in getting patients…
Seqster, PatientsLikeMe join forces to enhance clinical research
This collaboration, the healthcare technology companies say, promises to streamline clinical trial recruitment and optimize long-term patient engagement.…
LabWare and Mettler Toledo integrate software for lab efficiency
The connector seamlessly integrates LabWare’s Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN) with Mettler Toledo’s…
How SOMS is shaping the future of clinical trials
Kizewski delves into how SOMS is changing trial design, optimizing patient safety, and enhancing the chances of FDA…
Blood-based Alzheimer’s test set to revolutionize early diagnosis
The collaboration between ALZpath and Beckman Coulter marks a significant step toward making early detection more accessible and…
myTomorrows and Pancreatic Cancer Europe partner to aid patients
The partnership aims to enhance access to clinical trials for patients suffering from pancreatic cancer by leveraging myTomorrows’…
Unlocking drugs from microbial DNA: Empress Therapeutics’ mission
As head of platform development at Empress Therapeutics, Thompson uses her expertise to advance the company’s Chemilogics platform.…
Memorial Hermann expands life-changing cancer care partnership
This collaboration, which began in 2023, has significantly enhanced patient outcomes and healthcare efficiency through a hybrid model…
2M vaccines ready to fight mpox
Mpox is a viral infection with symptoms including rash and fever, and spreads through contact with body fluids,…
Melanie Adams-Cioaba on leading the cryo-EM revolution in drug discovery
As the senior director and general manager of pharma (Cryo-EM), Melanie is not only pioneering the use of…
DirectSens launches XpressGT for early diagnosis of critical conditions
The tool, aimed at research use only (RUO), promises to significantly improve early diagnostic capabilities in these areas.…
Nxera Pharma’s partnered schizophrenia candidate shows promise
Results from a phase 2 trial of the candidate schizophrenia drug, currently known as NBI-1117568, show that it…
Nasal spray for anaphylactic shock approved in Europe
The company, focused on solutions for severe allergic reactions was granted the approval last week, on August 22.…
Balversa Shows 36% reduced death risk in urothelial cancer
This approval marks the first pan-FGFR kinase inhibitor approved in the European Economic Area for this indication, providing…
Highlight 1 study to test fezolinetant in women with breast cancer
The first patient has been dosed, marking a significant step in addressing the needs of a patient population…
Blood-based Alzheimer’s test set to revolutionize early diagnosis
The collaboration between ALZpath and Beckman Coulter marks a significant step toward making early detection more accessible and…
ENA Respiratory advances study of nasal powder
The ongoing study, conducted at the Scientia Clinical Research facility in Sydney, Australia, is focused on evaluating the…
H1 partners with GRM to deliver critical aid in Ukraine
This collaboration builds on the success of H1’s earlier efforts in the Middle East following the Hamas attacks…
Amgen’s Otezla approved for pediatric plaque psoriasis
This marks a significant milestone as Otezla is the first FDA-approved oral medication for children and adolescents in…
Melanie Adams-Cioaba on leading the cryo-EM revolution in drug discovery
As the senior director and general manager of pharma (Cryo-EM), Melanie is not only pioneering the use of…
H1 partners with GRM to deliver critical aid in Ukraine
This collaboration builds on the success of H1’s earlier efforts in the Middle East following the Hamas attacks…
Women in Science – uMotif’s chief marketing officer, Elaine Maynard
Her journey, shaped by early experiences with illness in her family, has fueled Elaine’s commitment to advancing patient-centric…
Ayvakit drives 185% revenue surge in 2024 with strong global growth
This exceptional performance underscores the profound impact Ayvakit is having on patients with systemic mastocytosis (SM), a rare…
2M vaccines ready to fight mpox
Mpox is a viral infection with symptoms including rash and fever, and spreads through contact with body fluids,…
Accelerated FDA approval for primary biliary cholangitis treatment
This approval is particularly significant for patients who have had an inadequate response to ursodeoxycholic acid (UDCA), the…
Inside IQVIA’s innovative drug supply chain with Stefan Duerr
At the helm of innovation in this domain is Stefan Duerr, the senior director of product management and…
How Systech secures pharma supply chains from counterfeits
Through innovative platforms like UniSecure and UniTrace, Systech ensures unparalleled transparency, security, and compliance across global pharmaceutical supply…
nuVizz CEO on pharma supply chain solutions and innovation
The company also optimizes routes and ensures compliance with stringent industry regulations. Guru Rao, CEO of nuVizz, chats…
Boosting pharma supply chains – Certa on compliance and transparency
With regulations like the Drug Supply Chain Security Act (DSCSA) in the United States and the European Union…
TraceLink teams up with Tecsys
This collaboration seeks to address some of the most pressing challenges in healthcare, including compliance with the Drug…
Intelliguard and Cencora boost RFID medication compatibility
The collaboration is set to revolutionize the healthcare supply chain by increasing the compatibility between RFID (radio frequency…
Tonix Pharma offers hope to fibromyalgia sufferers
The news was shared at at the International Association for the Study of Pain (IASP) 2024 World Congress…
Almac Diagnostic Services’ Katarina Wikstrom
She obtained a PhD in experimental pathology from Lund University, and subsequently completed a postdoctoral fellowship on the…
Lonza expands manufacturing with bottling and labeling at US site
The upgrade includes the installation of advanced bottling and labeling equipment, aimed at enhancing early-phase clinical manufacturing services.…
PLAIO secures €4.3M to expand AI pharma planning platform
The funds will be deployed to expand its operations across the US and Europe, with a particular focus…
FDA approves needle-free epinephrine nasal spray for anaphylaxis
This marks the first significant innovation in epinephrine delivery in more than 35 years and offers an alternative…
Women in Science – uMotif’s chief marketing officer, Elaine Maynard
Her journey, shaped by early experiences with illness in her family, has fueled Elaine’s commitment to advancing patient-centric…
Expert insights on pharma outsourcing with CluePoints
To gain a deeper understanding of this complex landscape, OSP sat down with three industry experts from CluePoints:…
Harnessing technology for a new era in drug development
PhaseV, under the leadership of CEO Raviv Pryluk, stands at the forefront of this transformation. In this interview,…
FDA requests more trials for Lykos PTSD drug approval
The FDA has determined that the drug, aimed at treating PTSD, cannot be approved without further data and…
FDA poised to decide on Lykos’ MDMA therapy for PTSD
This decision follows a mixed response from the FDA advisory committee, which voted against recommending the treatment. However,…
Optimizing medical equipment maintenance strategies
Patel delves into the intricacies of equipment lifespan, cost management, downtime impact, and the importance of predictive maintenance,…
Partnership’s founding of institute to foster therapeutic innovation
As part of this alliance, Bruker has acquired a minority stake in NovAliX, and says this highlights the…